[go: up one dir, main page]

NO20083683L - Nebulisatorformulering - Google Patents

Nebulisatorformulering

Info

Publication number
NO20083683L
NO20083683L NO20083683A NO20083683A NO20083683L NO 20083683 L NO20083683 L NO 20083683L NO 20083683 A NO20083683 A NO 20083683A NO 20083683 A NO20083683 A NO 20083683A NO 20083683 L NO20083683 L NO 20083683L
Authority
NO
Norway
Prior art keywords
nebulisatorformulering
budesonide
copd
asthma
disorders
Prior art date
Application number
NO20083683A
Other languages
English (en)
Inventor
Ian Gardner Cameron Mcaffer
Peter Ernest Tasko
Original Assignee
Breath Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Breath Ltd filed Critical Breath Ltd
Publication of NO20083683L publication Critical patent/NO20083683L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

En steril forstøverformulering som inneholder formoterol og budesonid i omtrent 2 ml eller mindre av saltoppløsning og som er for behandling av COPD og astma og andre luftveissykdommer og lidelser.
NO20083683A 2006-03-01 2008-08-27 Nebulisatorformulering NO20083683L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0604141.2A GB0604141D0 (en) 2006-03-01 2006-03-01 Nebulizer formulation
PCT/GB2007/000722 WO2007099329A2 (en) 2006-03-01 2007-03-01 Nebulizer formulation

Publications (1)

Publication Number Publication Date
NO20083683L true NO20083683L (no) 2008-12-01

Family

ID=36218946

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20083683A NO20083683L (no) 2006-03-01 2008-08-27 Nebulisatorformulering

Country Status (14)

Country Link
US (1) US20070207091A1 (no)
EP (1) EP1988876A2 (no)
JP (1) JP2009528337A (no)
KR (1) KR20080098631A (no)
CN (1) CN101394835A (no)
AU (1) AU2007220288B2 (no)
BR (1) BRPI0708170A2 (no)
CA (1) CA2643761A1 (no)
GB (1) GB0604141D0 (no)
IL (1) IL193369A0 (no)
NO (1) NO20083683L (no)
NZ (1) NZ570432A (no)
WO (1) WO2007099329A2 (no)
ZA (1) ZA200806929B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0501956D0 (en) * 2005-01-31 2005-03-09 Arrow Internat Nebulizer formulation
GB0700380D0 (en) * 2007-01-09 2007-02-14 Breath Ltd Storage Of Ampoules
US20100055045A1 (en) * 2008-02-26 2010-03-04 William Gerhart Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations
NZ587561A (en) * 2008-02-26 2012-10-26 Elevation Pharmaceuticals Inc Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations (an muscarinic antagnoist)
CA2764867C (en) * 2009-06-09 2016-05-17 Elevation Pharmaceuticals, Inc. Treatment of chronic obstructive pulmonary disease with nebulized beta 2-agonist or combined nebulized beta 2-agonist and anticholinergic administration
US20140296641A1 (en) * 2013-03-28 2014-10-02 William Randolph Warner COMPOSITIONS, FORMULATIONS AND METHODS OF BIO-BALANCING THE pH OF STERILE HYPOTONIC, ISOTONIC SALINE AND HYPERTONIC SALINE SOLUTIONS
GB201416909D0 (en) * 2014-09-25 2014-11-12 Prosonix Ltd Method of forming concentrated solution
CN107233311B (zh) * 2017-06-27 2020-12-04 长风药业股份有限公司 一种以阿福特罗和格隆溴铵为活性成分的雾化剂及其制备方法
US20190231769A1 (en) * 2017-10-27 2019-08-01 Nephron Pharmaceuticals Corporation Tiotropium Inhalation Solution for Nebulization

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK285910B6 (sk) * 1991-12-18 2007-10-04 Aktiebolaget Astra Medicinálny produkt obsahujúci kombináciu formoterolu a budesonidu
SE9703407D0 (sv) * 1997-09-19 1997-09-19 Astra Ab New use
US6946117B1 (en) * 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US6565885B1 (en) * 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
SE9802073D0 (sv) * 1998-06-11 1998-06-11 Astra Ab New use
US7074388B2 (en) * 1998-12-10 2006-07-11 Kos Life Science, Inc. Water stabilized medicinal aerosol formulation
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
IT1313553B1 (it) * 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
US20060171897A1 (en) * 1999-12-23 2006-08-03 Coifman Robert E Methods and formulations for the efficient delivery of drugs by nebulizer
US6451289B2 (en) * 2000-03-24 2002-09-17 Sepracor Inc. Albuterol formulations
GB0009584D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Pharmaceutical compositions
NZ526118A (en) * 2000-11-24 2004-10-29 Breath Ltd Sterilisation of pharmaceutical containing glucocorticosteroid by rapid heating and cooling
ITMI20010428A1 (it) * 2001-03-02 2002-09-02 Chemo Breath S A Composizioni ad uso inalatorio a base di formoterolo
US20030055026A1 (en) * 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US6667344B2 (en) * 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
SE0200312D0 (sv) * 2002-02-01 2002-02-01 Astrazeneca Ab Novel composition
EP1476201B1 (en) * 2002-02-19 2008-12-24 Resolution Chemicals Limited Solvent-based sterilisation of steroids
SE0203376D0 (sv) * 2002-11-15 2002-11-15 Astrazeneca Ab New process
SE526509C2 (sv) * 2003-06-19 2005-09-27 Microdrug Ag Kombinerade doser av formoterol och budesonid separerade på en gemensam dosbädd
DE10347994A1 (de) * 2003-10-15 2005-06-16 Pari GmbH Spezialisten für effektive Inhalation Wässrige Aerosol-Zubereitung
US20050214224A1 (en) * 2003-11-04 2005-09-29 Nektar Therapeutics Lipid formulations for spontaneous drug encapsulation
EP1696875A2 (en) * 2003-12-12 2006-09-06 Joseph Okpala A method of engineering particles for use in the delivery of drugs via inhalation
US20070020299A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
EP1712220A1 (en) * 2005-04-15 2006-10-18 PARI GmbH Spezialisten für effektive Inhalation Pharmaceutical aerosol composition

Also Published As

Publication number Publication date
NZ570432A (en) 2010-09-30
WO2007099329A2 (en) 2007-09-07
JP2009528337A (ja) 2009-08-06
WO2007099329A3 (en) 2007-10-25
KR20080098631A (ko) 2008-11-11
CN101394835A (zh) 2009-03-25
EP1988876A2 (en) 2008-11-12
CA2643761A1 (en) 2007-09-07
US20070207091A1 (en) 2007-09-06
AU2007220288B2 (en) 2012-12-13
ZA200806929B (en) 2009-11-25
GB0604141D0 (en) 2006-04-12
BRPI0708170A2 (pt) 2011-05-17
AU2007220288A1 (en) 2007-09-07
IL193369A0 (en) 2009-05-04

Similar Documents

Publication Publication Date Title
NO20083683L (no) Nebulisatorformulering
NO20075287L (no) Kombinasjon av antikolinergika og leukotnen-reseptorantagonister for behandling av andedrettslidelser
UY26959A1 (es) Nuevos polvos para inhalación que contienen tiotropio
CA2474479A1 (en) Composition for inhalation
MEP30108A (en) Formoterol superfine formulation
NO20072920L (no) Kombinasjon av metylxantinforbindelser og steroider for a behandle kroniske respirasjonssykdommer
NO20063047L (no) Vandige ciclesonidsuspensjoner for forstoving
JP2010132695A5 (no)
BR0212453A (pt) Aparelho de assistência respiratória
ATE330589T1 (de) Pharmazeutische zusammensetzung enthaltend resveratrol zur behandlung von entzündlichen erkrankungen der atemwege
NO20073909L (no) Forstover-formulering
UA98136C2 (ru) Применение аклидиния для лечения респираторных заболеваний
UY27757A1 (es) Medicamento que contiene betamiméticos y un nuevo anticolinérgico.
MD4369B1 (ro) Utilizarea glicopirolatului pentru tratarea tahicardiei, doză unică, dispozitiv de administrare, metodă de tratament şi profilaxie a tahicardiei
NO20081480L (no) Kombinasjon av forbindelser som kan brukes ved behandling av respiratoriske sykdommer, spesielt kronisk obstruktiv pulmonaer sykdom (COPD) og astma
Sanders et al. A rationale for going back to the future: use of disposable spacers for pressurised metered dose inhalers
KR20170033925A (ko) 항바이러스 및 세균용 스프레이 조성물
EP2380569A3 (de) Osmolyte zur Behandlung von allergisch oder viral bedingten Atemwegserkrankungen
EA200500328A1 (ru) Композиция и лекарственное средство для лечения респираторных заболеваний, аллергических заболеваний, астмы и/или хронических обструктивных заболеваний легких и способ получения лекарственного средства
MX2009005370A (es) Uso de inhibidores de arginasa en el tratamiento de asma y rinitis alergica.
NO20061441L (no) Nye tiotropiumsalter, metoder for deres fremstilling, og farmasoytiske formuleringer inneholdende disse
NO20054767L (no) Sammensetninger omfattende apomorfin for inhalering i lunge
NO20061440L (no) Metode fo fremstilling av tiotropiumsalter og farmasoytiske formuleringer inneholdende samme.
NO20082439L (no) Anvendelse av tiotropiumsalter for behandling av moderat vedvarende astma
MX2010004529A (es) Composiciones de inhalacion que comprenden acido montelukast y un inhibidor de fosfodiesterasa-4 o un corticoesteroide inhalado.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application